Discover 698 paid clinical trials in Oklahoma. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Oklahoma offers many options for individuals interested in paid research studies as both healthy participants and those with specific health conditions. Leading research centers in Oklahoma City, Tulsa, and Norman are recruiting volunteers, giving access to the latest treatments and specialized care.
Filter
1
Filter results
Results: 698
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
for
Myelodysplastic Syndrome
Location: Boston MA, Lebanon NH, Stony Brook NY, Long Branch NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06577441
Phase2, Recruiting
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
Location: Halifax, Scarborough ME, Boston MA, Providence RI,
Sponsor: Children's Oncology Group
Sex: All
Age: 3 - 29
Code: NCT06368817
Phase2, Recruiting
Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
Location: Charlotte NC, Memphis TN, Tulsa OK, San Diego CA
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 1 - 18
Code: NCT06390319
Phase2, Recruiting
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
for
Refractory Angina
Location: Boston MA, Springfield MA, New Haven CT, Quebec,
Sponsor: Shockwave Medical, Inc.
Sex: All
Age: 18+
Code: NCT05102019
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Synaptic Plasticity in the Epicardial Ganglionated Plexi
for
Atrial Fibrillation
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: All
Age: 21 - 70+
Code: NCT05034419
Phase1, Recruiting
Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial
for
Nodular Lymphocyte Predominant B-Cell Lymphoma,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05886036
Phase2, Recruiting
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
for
Cancer
Location: New Brunswick NJ, Silver Spring MD, Bethesda MD,
Sponsor: Tizona Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT04485013
Phase1, Recruiting
Analgesic Comparison of PENG/LFCN to FICB for Total Hip Arthroplasty
for
Analgesia
Location: Oklahoma City OK
Sponsor: SSM Health Bone and Joint Hospital at St Anthony
Sex: All
Age: 40 - 70+
Code: NCT05477641
Recruiting
Study to Assess Allogeneic Anti-CD38 A2 Dimeric Antigen Receptor T Cells in Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Oklahoma City OK
Sponsor: Sorrento Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05007418
Phase1, Recruiting
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
for
Asthma
Location: South Dartmouth MA, Boston MA, Jersey City NJ,
Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
for
Recurrent or Refractory Solid Tumors, Ewing Sarcoma,